Equities

IGEA Pharma NV

IGEA Pharma NV

Actions
  • Price (CHF)0.25
  • Today's Change-0.02 / -7.41%
  • Shares traded91.87k
  • 1 Year change-56.52%
  • Beta--
Data delayed at least 15 minutes, as of Dec 08 2021 15:46 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • IGPH:SWX trading volume exceeds daily average by +55.90%
  • IGPH:SWX price reached a new 52-week low of 0.25 at 14:46 GMT
  • IGPH:SWX price moved over +18.52% to 0.32
  • IGPH:SWX price rises above 15-day moving average to 0.32 at 09:05 GMT

Key statistics

IGEA Pharma NV (IGPH:SWX) set a new 52-week low during today's trading session when it reached 0.242. Over this period, the share price is down -56.14%.
52-week range
Today
0.242Dec 08 20210.70Feb 18 2021
Markit short selling activity
Low
Med
High
Open0.32
High0.32
Low0.242
Bid0.24
Offer0.25
Previous close0.270
Average volume23.04k
Shares outstanding334.72m
Free float275.49m
P/E (TTM)--
Market cap90.33m CHF
EPS (TTM)-0.0326
CHF
Data delayed at least 15 minutes, as of Dec 08 2021 15:46 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.